Quarterly Journal of Nuclear Medicine and Molecular Imaging

Papers
(The TQCC of Quarterly Journal of Nuclear Medicine and Molecular Imaging is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Osteomyelitis in complicated bones: the role of FDG PET/CT22
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study21
Targeted alpha therapy in prostate cancer: review of available agents in clinical practice17
Nuclear cardiac imaging for the diagnosis and management of heart failure: what can be learned from recent guidelines?15
Current radioisotopes and radiopharmaceuticals for radiosynoviorthesis: basic and applied characteristics, production and availability13
Pediatric nuclear medicine: continuing the evolution12
[68Ga]DOTA-TATE PET for the detection of early transplant rejection in a heterotopic allograft heart transplantation model of the rat: a pilot study11
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus10
Current and future trends of [18F]FDG PET/CT in pediatric Hodgkin lymphoma9
Combination prostate-specific membrane antigen-targeted radiopharmaceutical therapy in metastatic prostate cancer9
The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response9
[18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?8
Second radioiodine treatment hardly benefits TT-DTC patients with radioiodine-negative metastases on initial post-therapeutic whole-body scans7
Stereotactic body radiation therapy for the re-irradiation of local relapse from prostate cancer: results in terms of outcomes and toxicity7
Radiopharmaceuticals for lung ventilation scintigraphy7
The value of artificial intelligence in PSMA PET: a pathway to improved efficiency and results7
[18F]FDG and [68Ga]Ga-PSMA dual-tracer total-body PET/CT and PET/MR in patients with prostate cancer7
Radiation protection aspects for alpha therapies6
Volumetric PET parameters are predictive for the prognosis of locally advanced cervical cancer6
Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma6
FDG PET/CT in vascular graft infection: a pictorial review6
Contemporary SPECT/CT V/Q scanning: protocols, pearls and pitfalls6
Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imaging5
Technical concepts on blood pool phase SPECT (acquisition, reconstruction)5
Imaging of dopamine transporter with [18F]LBT-999: initial evaluation in healthy volunteers5
Nuclear medicine and pediatric nephro-urology: a long-lasting successful partnership5
Role and interpretation of lung scintigraphy for long-term management of pulmonary embolism5
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors4
The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella review4
11C-methionine PET/MRI in postoperative patients after craniotomy: zero echo time and head atlas versus CT-based attenuation correction4
Fever of unknown origin in pediatrics: role of nuclear medicine4
Perceptual omission errors in positron emission tomography and computed tomography reporting4
Innovations in imaging modalities: a comparative review of MRI, long-axial field-of-view PET, and full-ring CZT-SPECT in detecting bone metastases3
Emerging topics in neuroimaging3
The revolution of prostate cancer management with nuclear medicine: transforming diagnosis and treatment3
F18-FET PET in pediatric brain tumors: integrative analysis of image derived parameters and clinico-pathological data3
Novel imaging predictors in pediatric lymphoma: radiomics and artificial intelligence. A systematic review3
Local treatment of synovitis3
Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center study3
Benefit of including CT urography in [68Ga]PSMA-11 PET/CT with low-dose CT: first results from a larger prostate cancer cohort analysis3
[18F]FDG PET/CT for the diagnosis of diabetic foot osteomyelitis3
0.053932905197144